In this free webinar, gain insights into how regulators are encouraging clinical trial innovation. The featured speaker will discuss methods and resources for determining the compliance implications of new technologies. Attendees will learn what technologies are available to improve data quality as well as decreasing site and patient burden.
TORONTO, Nov. 28, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into regulatory innovations in clinical trials, assessing new tech compliance and enhancing data quality while reducing site and patient burden. Innovation in clinical trials historically has been slow, and people often point to regulations and regulators as the reason. Are regulators truly the bottleneck? In this webinar, Jonathan Andrus makes the argument that regulators are actually a driving force behind innovation. This webinar will provide examples across the clinical trials process where regulators are not only supporting but encouraging innovation, including:
- Study design — requesting patient input on protocols, using novel trial designs that reduce patient burden, advancing risk-based approaches
- Study conduct — risk-based approaches to monitoring and study oversight, use of real-world evidence
- Post-study — faster approvals and adaptive pathways, early access to promising treatments, expanded use of post-market surveillance
Internal quality assurance (QA) and regulatory teams can be a hold-up when they rely on historical practices and personal preference rather than current regulatory guidance in assessing the feasibility and risks of implementing new and innovative solutions to clinical trial challenges. It's time for sponsors, contract research organizations (CROs) and technology vendors to step up and join the evolution of clinical data management to data science — a strategic discipline enabling the execution of complex protocol designs in a patient-centric, data-driven and risk-based approach to ensuring subject protection as well as the validity of trial results.
This webinar will also include a real-life example of how CRIO used direct communication with regulators to resolve questions about the implementation of single sign-on (SSO) with electronic signatures — an area where previous regulatory guidance was ambiguous and predated the current infrastructure of SSO. Through these interactions, CRIO was able to achieve a path forward that is compliant, innovative and meets the needs of their clients.
Join this webinar to gain insights into how regulators encourage clinical trial innovation, methods for assessing compliance implications of new technologies and available technologies to improve data quality and reduce site and patient burdens.
Join Jonathan Andrus, President & COO, CRIO, for the live webinar on Tuesday, December 12, 2023, at 11 am EST (4 pm GMT/UK).
For more information, or to register for this event, visit Are Regulators Driving or Impeding Innovation in Clinical Trials?
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com
SOURCE Xtalks
Share this article